dobutamine has been researched along with bisoprolol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodde, OE; Ikezono, K; Reidemeister, JC; Rohm, N; Zerkowski, HR | 1 |
| Brodde, OE; Daul, A; Hermes, U; Schäfers, RF; von Birgelen, C; Wenzel, R | 1 |
| Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C | 1 |
| Brodde, OE; Bruck, H; Heusch, G; Leineweber, K; Philipp, T; Temme, T; Weber, M | 1 |
| Chia, PL; Lee, E | 1 |
| Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
1 review(s) available for dobutamine and bisoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dobutamine and bisoprolol
| Article | Year |
|---|---|
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
Topics: Adrenergic beta-Antagonists; Aorta, Abdominal; Bisoprolol; Dobutamine; Echocardiography; Femoral Artery; Follow-Up Studies; Heart Diseases; Humans; Myocardial Infarction; Myocardial Ischemia; Postoperative Complications; Risk Factors; Survival Analysis; Time Factors; Vascular Surgical Procedures | 2001 |
10 other study(ies) available for dobutamine and bisoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.
Topics: Adrenergic beta-Agonists; Adult; Aged; Bisoprolol; Dobutamine; Dose-Response Relationship, Drug; Ethanolamines; Female; Heart Atria; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Procaterol; Propanolamines; Receptors, Adrenergic, beta; Stimulation, Chemical | 1986 |
The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
Topics: Adult; Bisoprolol; Blood Pressure; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Humans; Infusions, Intravenous; Male; Propranolol; Receptors, Adrenergic, beta; Tachycardia | 1995 |
The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
Topics: Adrenergic beta-Antagonists; Adult; Arginine; Bisoprolol; Dobutamine; Dose-Response Relationship, Drug; Genotype; Glycine; Hemodynamics; Humans; Male; Polymorphism, Genetic; Receptors, Adrenergic, beta-1; Renin; Stroke Volume; Ventricular Function, Left | 2005 |
Reverse Takotsubo pattern stress cardiomyopathy in a male patient induced during dobutamine stress echocardiography.
Topics: Aspirin; Bisoprolol; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Dobutamine; Echocardiography, Stress; Enalapril; Humans; Male; Middle Aged; Simvastatin | 2012 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |